PARTICIPATION OF MITOCHONDRIAL DIAZEPAM BINDING INHIBITOR RECEPTORS IN THE ANTICONFLICT, ANTINEOPHOBIC AND ANTICONVULSANT ACTION OF 2-ARYL-3-INDOLEACETAMIDE AND IMIDAZOPYRIDINE DERIVATIVES
J. Auta et al., PARTICIPATION OF MITOCHONDRIAL DIAZEPAM BINDING INHIBITOR RECEPTORS IN THE ANTICONFLICT, ANTINEOPHOBIC AND ANTICONVULSANT ACTION OF 2-ARYL-3-INDOLEACETAMIDE AND IMIDAZOPYRIDINE DERIVATIVES, The Journal of pharmacology and experimental therapeutics, 265(2), 1993, pp. 649-656
The 2-hexyl-indoleacetamide derivative, FGIN-1-27 -di-n-hexyl-2-(4-flu
orophenyl)indole-3-acetamide], and the imidazopyridine derivative, alp
idem, both bind with high affinity to glial mitochondrial diazepam bin
ding inhibitor receptors (MDR) and increase mitochondrial steroidogene
sis. Although FGIN-1-27 is selective for the MDR, alpidem also binds t
o the allosteric modulatory site of the gamma-aminobutyric acid(A) rec
eptor where the benzodiazepines bind. FGIN-1-27 and alpidem, like the
neurosteroid 3alpha,21-dehydroxy-5alpha-pregnane-20-one (THDOC), clona
zepam and zolpidem (the direct allosteric modulators of gamma-aminobut
yric acid(A) receptors) delay the onset of isoniazid and metrazol-indu
ced convulsions. The anti-isoniazid convulsant action of FGIN-1-27 and
alpidem, but not that of THDOC, is blocked by PK 11195. In contrast,
flumazenil blocked completely the anticonvulsant action of clonazepam
and zolpidem and partially blocked that of alpidem, but it did not aff
ect the anticonvulsant action of THDOC and FGIN-1-27. Alpidem, like cl
onazepam, zolpidem and diazepam, but not THDOC or FGIN-1-27, delay the
onset of bicuculline-induced convulsions. In two animal models of anx
iety, the neophobic behavior in the elevated plus maze test and the co
nflict-punishment behavior in the Vogel conflict test, THDOC and FGIN-
1-27 elicited anxiolytic-like effects in a manner that is flumazenil i
nsensitive, whereas alpidem elicited a similar anxiolytic effect, but
is partially blocked by flumazenil. Whereas PK 11195 blocked the effec
t of FGIN-1-27 and partially blocked alpidem, it did not affect THDOC
in both animal models of anxiety. Because both alpidem and FGIN-1-27 b
ind to MDR and stimulate mitochondrial steroid biosynthesis, the behav
ioral effects of FGIN-1-27 and in part alpidem may be mediated via MDR
-induced steroidogenesis.